We have collected the most relevant information on Claudio Dansky Ullmann Md. Open the URLs, which are collected below, and you will find all the info you are interested in.


Claudio Dansky Ullmann M.D. - Chief Medical Officer ...

    https://www.linkedin.com/in/claudio-dansky-ullmann-m-d-a9675968
    Claudio Dansky Ullmann M.D. Chief Medical Officer at CARMA Cell Therapies, MaxCyte, Inc. Gaithersburg, Maryland, United States500+ connections Join to Connect CARMA Cell …

Clinical Investigations Branch (CIB) | CTEP

    https://ctep.cancer.gov/branches/cib/bios/dansky-ullman.htm
    Claudio Dansky-Ullmann, MD Head - Lung Cancer, Thoracic, Head - Neck, Melanoma Cancer Therapeutics. Contact Information: National Cancer Institute 6130 Executive Blvd., Suite 7025 Bethesda, MD 20892-7436 Phone: 301-435-9065 E-mail: [email protected]

Claudio Dansky Ullmann - Chief Medical Officer CARMA Cell ...

    https://execlibrary.com/executive/claudio-dansky-ullmann/
    Gaithersburg, MD , United States Biography Dr. Dansky Ullmann, a 25+-year expert in clinical oncology and pharmaceutical research, is responsible for overseeing clinical development of MaxCyte’s CARMA™ drug development program. Dr. Dansky Ullmann was most recently the senior vice president and hea ... Show more » Current Job Past Experience

Claudio Dansky Ullmann MD's email & phone number - Chief ...

    https://www.signalhire.com/profiles/claudio-dansky-ullmann-md%27s-email/59641778
    According to LinkedIn Claudio Dansky Ullmann MD started working on 2015, then the employee has changed 1 company and 2 jobs. On average, Claudio Dansky Ullmann MD works for one company for 1 year 10 months. Claudio Dansky Ullmann MD has been working as a Chief Medical Officer for CARMA Cell Therapies, MaxCyte, Inc. for 1065 days.

MaxCyte - MaxCyte Appoints Dr.Claudio Dansky Ullmann as ...

    https://maxcyte.com/maxcyte-appoints-dr-claudio-dansky-ullmann-as-chief-medical-officer/
    dr. dansky ullmann was most recently the senior vice president and head of clinical development at infinity pharmaceuticals, where, as part of the executive leadership team, he oversaw all clinical development and operations, shaped corporate strategy, and was directly involved in business development activities as well as investor and analyst …

MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief ...

    https://markets.financialcontent.com/stocks/news/read?GUID=36186552
    GAITHERSBURG, Md., April 25, 2018 /PRNewswire/ -- MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in clinical oncology and pharmaceutical research, as its Chief Medical Officer (CMO).In his new role, Dr. Dansky Ullmann is responsible for overseeing …

MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief ...

    https://www.biospace.com/article/releases/maxcyte-appoints-dr-claudio-dansky-ullmann-as-chief-medical-officer/
    GAITHERSBURG, Md., April 25, 2018 /PRNewswire/ -- MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in clinical oncology and pharmaceutical research, as its Chief Medical Officer (CMO).In his new role, Dr. Dansky Ullmann is responsible for overseeing …

Claudio Ullmann, 61 - Potomac | Free Public Reputation …

    https://www.mylife.com/claudio-ullmann/e157063813800
    See Free Details & Reputation Profile for Claudio Ullmann (61) in Potomac, MD. Includes free contact info & photos + criminal & court records.

MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief ...

    https://baltimore.citybizlist.com/article/477606/maxcyte-appoints-dr-claudio-dansky-ullmann-as-chief-medical-officer
    MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in clinical oncology and pharmaceutical research, as its Chief Medical Officer (CMO).In his new role, Dr. Dansky Ullmann is responsible for overseeing clinical development of MaxCyte's CARMA™ drug …

Head and neck squamous cell cancer and the human ...

    https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-squamouscellhumanpapillomavirus-publication200911.pdf
    Arlene Forastiere, MD,6 Claudio Dansky Ullmann, MD4 1Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. E-mail: [email protected] 2Fox Chase Cancer Center, Philadelphia, Pennsylvania 3Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Now you know Claudio Dansky Ullmann Md

Now that you know Claudio Dansky Ullmann Md, we suggest that you familiarize yourself with information on similar questions.